BIOMAT Database Logo BIOMAT Database Logo

Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells. 2000

L Bulteau, and R Dérand, and Y Mettey, and T Métayé, and M R Morris, and C M McNeilly, and C Folli, and L J Galietta, and O Zegarra-Moran, and M M Pereira, and C Jougla, and R L Dormer, and J M Vierfond, and M Joffre, and F Becq
Laboratoire de Physiologie des Régulations Cellulaires, Unité Mixte de Recherche 6558, 86022 Poitiers, France.

The pharmacological activation of the cystic fibrosis gene protein cystic fibrosis transmembrane conductance regulator (CFTR) was studied in human airway epithelial Calu-3 cells, which express a high level of CFTR protein as assessed by Western blot and in vitro phosphorylation. Immunolocalization shows that CFTR is located in the apical membrane. We performed iodide efflux, whole cell patch-clamp, and short-circuit recordings to demonstrate that the novel synthesized xanthine derivative 3, 7-dimethyl-1-isobutylxanthine (X-33) is an activator of the CFTR channel in Calu-3 cells. Whole cell current activated by X-33 or IBMX is linear, inhibited by glibenclamide and diphenylamine-2-carboxylate but not by DIDS or TS-TM calix[4]arene. Intracellular cAMP was not affected by X-33. An outwardly rectifying Cl(-) current was recorded in the absence of cAMP and X-33 stimulation, inhibited by DIDS and TS-TM calix[4]arene. With the use of short-circuit recordings, X-33 and IBMX were able to stimulate a large concentration-dependent CFTR transport that was blocked by glibenclamide but not by DIDS. Our results show that manipulating the chemical structure of xanthine derivatives offers an opportunity to identify further specific activators of CFTR in airway cells.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007454 Iodides Inorganic binary compounds of iodine or the I- ion. Iodide
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D010726 Phosphodiesterase Inhibitors Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterase Antagonists,Phosphodiesterase Inhibitor,Phosphoric Diester Hydrolase Inhibitors,Antiphosphodiesterases,Inhibitor, Phosphodiesterase
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002712 Chlorides Inorganic compounds derived from hydrochloric acid that contain the Cl- ion. Chloride,Chloride Ion Level,Ion Level, Chloride,Level, Chloride Ion

Related Publications

L Bulteau, and R Dérand, and Y Mettey, and T Métayé, and M R Morris, and C M McNeilly, and C Folli, and L J Galietta, and O Zegarra-Moran, and M M Pereira, and C Jougla, and R L Dormer, and J M Vierfond, and M Joffre, and F Becq
CFTR in Calu-3 human airway cells: channel properties and role in cAMP-activated Cl- conductance.
May 1994, The American journal of physiology,
L Bulteau, and R Dérand, and Y Mettey, and T Métayé, and M R Morris, and C M McNeilly, and C Folli, and L J Galietta, and O Zegarra-Moran, and M M Pereira, and C Jougla, and R L Dormer, and J M Vierfond, and M Joffre, and F Becq
Calcium-stimulated Cl- secretion in Calu-3 human airway cells requires CFTR.
December 1997, The American journal of physiology,
L Bulteau, and R Dérand, and Y Mettey, and T Métayé, and M R Morris, and C M McNeilly, and C Folli, and L J Galietta, and O Zegarra-Moran, and M M Pereira, and C Jougla, and R L Dormer, and J M Vierfond, and M Joffre, and F Becq
CFTR-Mediated anion conductance regulates Na(+)-K(+)-pump activity in Calu-3 human airway cells.
July 2000, Biochemical and biophysical research communications,
L Bulteau, and R Dérand, and Y Mettey, and T Métayé, and M R Morris, and C M McNeilly, and C Folli, and L J Galietta, and O Zegarra-Moran, and M M Pereira, and C Jougla, and R L Dormer, and J M Vierfond, and M Joffre, and F Becq
Bile acids stimulate chloride secretion through CFTR and calcium-activated Cl- channels in Calu-3 airway epithelial cells.
September 2014, American journal of physiology. Lung cellular and molecular physiology,
L Bulteau, and R Dérand, and Y Mettey, and T Métayé, and M R Morris, and C M McNeilly, and C Folli, and L J Galietta, and O Zegarra-Moran, and M M Pereira, and C Jougla, and R L Dormer, and J M Vierfond, and M Joffre, and F Becq
ATP release triggered by activation of the Ca2+-activated K+ channel in human airway Calu-3 cells.
March 2004, American journal of respiratory cell and molecular biology,
L Bulteau, and R Dérand, and Y Mettey, and T Métayé, and M R Morris, and C M McNeilly, and C Folli, and L J Galietta, and O Zegarra-Moran, and M M Pereira, and C Jougla, and R L Dormer, and J M Vierfond, and M Joffre, and F Becq
Editorial Focus: CFTR-dependent bicarbonate secretion by Calu-3 cells.
May 2018, Physiological reports,
L Bulteau, and R Dérand, and Y Mettey, and T Métayé, and M R Morris, and C M McNeilly, and C Folli, and L J Galietta, and O Zegarra-Moran, and M M Pereira, and C Jougla, and R L Dormer, and J M Vierfond, and M Joffre, and F Becq
Effect of ouabain on CFTR gene expression in human Calu-3 cells.
March 2003, American journal of physiology. Cell physiology,
L Bulteau, and R Dérand, and Y Mettey, and T Métayé, and M R Morris, and C M McNeilly, and C Folli, and L J Galietta, and O Zegarra-Moran, and M M Pereira, and C Jougla, and R L Dormer, and J M Vierfond, and M Joffre, and F Becq
Ion transport regulated by protease-activated receptor 2 in human airway Calu-3 epithelia.
October 2005, British journal of pharmacology,
L Bulteau, and R Dérand, and Y Mettey, and T Métayé, and M R Morris, and C M McNeilly, and C Folli, and L J Galietta, and O Zegarra-Moran, and M M Pereira, and C Jougla, and R L Dormer, and J M Vierfond, and M Joffre, and F Becq
Regulation of intracellular pH in Calu-3 human airway cells.
January 2002, The Journal of physiology,
L Bulteau, and R Dérand, and Y Mettey, and T Métayé, and M R Morris, and C M McNeilly, and C Folli, and L J Galietta, and O Zegarra-Moran, and M M Pereira, and C Jougla, and R L Dormer, and J M Vierfond, and M Joffre, and F Becq
Apical adenosine regulates basolateral Ca2+-activated potassium channels in human airway Calu-3 epithelial cells.
June 2008, American journal of physiology. Cell physiology,
Copied contents to your clipboard!